Exploring potential biomarkers and therapeutic targets in inflammatory bowel disease: insights from a mega-analysis approach
BackgroundUnderstanding the molecular pathogenesis of inflammatory bowel disease (IBD) has led to the discovery of new therapeutic targets that are more specific and effective. Our aim was to explore the molecular pathways and genes involved in IBD pathogenesis and to identify new therapeutic target...
Main Authors: | Edia Stemmer, Tamar Zahavi, Maoz Kellerman, Liat Anabel Sinberger, Guy Shrem, Mali Salmon‐Divon |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1353402/full |
Similar Items
-
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
by: Liat Anabel Sinberger, et al.
Published: (2023-11-01) -
INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01) -
Inflammatory bowel disease in children
by: Maciej Putowski, et al.
Published: (2019-08-01) -
Prevalence of inflammatory bowel disease in the Chelyabinsk Region
by: A. I. Dolgushina, et al.
Published: (2019-12-01) -
Clinicopathological features of inflammatory bowel disease in Benin City, Nigeria
by: Darlington Ewaen Obaseki, et al.
Published: (2014-01-01)